Dr Reddy's, Hetero sign voluntary licenses with Gilead for HIV drug
Gilead Sciences first launched lenacapavir under the brand name Sunlenca in the United States and European markets in 2022.
cnbctv181h
Dr. Reddy's inks licensing pact with Gilead to commercialise HIV drug
Lenacapavir is a US Food and Drug Administration (FDA) approved medication indicated for the treatment of HIV type 1 (HIV-1) ...
moneycontrol.com1h
Dr Reddy’s enters pact with Gilead Sciences to manufacture, sell HIV drug Lenacapavir in India and 120 countries
Dr Reddy’s Laboratories said it has entered into a royalty-free non-exclusive voluntary licensing agreement with Gilead ...
Dr Reddy's ties up with Gilead to manufacture, commercialise HIV drug
Dr Reddy's Laboratories on Wednesday said it has tied up with Gilead Sciences for the manufacture and commercialisation of ...
Dr Reddy's completes acquisition of UK co Haleon's non-US nicotine replacement therapy biz
Hyderabad-based pharma giant Dr Reddy’s Ltd finalizes its largest acquisition by buying British Haleon Plc’s non-US nicotine ...
Dr Reddy's completes acquisition of Haleon's NRT portfolio
Dr Reddy's Laboratories has acquired Haleon's global Nicotine Replacement Therapy (NRT) portfolio, excluding the US, for GBP ...
Business Line2d
Dr Reddy’s completes acquisition of Haleon Plc’s global portfolio of consumer healthcare brands in NRT
Dr Reddy’s Laboratories SA, Switzerland, an arm of Dr Reddy’s Laboratories, has completed the previously-announced ...
Dr. Reddy's Laboratories rises Thursday, still underperforms market
Shares of Dr. Reddy's Laboratories Ltd. 500124 inched up 0.74% to 6,743.20 Indian rupees Thursday, on what proved to be an ...
Dr. Reddy's Laboratories Stocks Live Updates: Dr. Reddy's Laboratories Posts 3.03% Weekly Increase, Closing at Rs 6749.90
Stay updated with the Dr. Reddy's Laboratories Stock Liveblog, your one-stop destination for real-time information and ...
cnbctv184d
Dr Reddy’s invests $620 million in Swiss subsidiary for Nicotinell brand acquisition
Drug maker Dr Reddy's Laboratories Ltd on Friday (September 27) said it has invested $620 million in its wholly-owned ...
Dr. Reddy's Laboratories Share Price Today Updates: Dr. Reddy's Laboratories Sees Minor Daily Decline Amid Positive Six-Month Returns
Welcome to the Dr. Reddy's Laboratories Stock Liveblog, your ultimate source for real-time updates and analysis of one of the ...
The Week1d
Dr Nilay Reddy of Hyderabad LV Prasad Eye Hospital dies in Outer Ring Road car accident
Dr. Nilay Reddy, 29, a Cornea and Anterior Segment Fellow at the LV Prasad Eye Hospital, was travelling to the airport from ...